Home / Companies / Sun Pharmaceutical Industries

Sun Pharmaceutical Industries

PharmaceuticalsMumbai, India

Mumbai-headquartered pharmaceutical company, India's largest by revenue and among the world's biggest generic drugmakers. It has been shifting its earnings mix towards specialty products in dermatology, ophthalmology and oncology, with ILUMYA among its lead specialty assets. Listed on the NSE and BSE.

1StartupFox story
1983Founded
PharmaceuticalsSector
Oct 2026Latest coverage

Leadership

DSDilip ShanghviFounder and Managing Director
RARick AscroftChief Executive Officer, North America
CSC. S. MuralidharanChief Financial Officer

The Sun Pharmaceutical Industries journey

1983 · founded
Founded in Mumbai.
2018 · milestone
ILUMYA (tildrakizumab-asmn) receives first US FDA approval, for adults with moderate-to-severe plaque psoriasis. ↗
Oct 2026 · milestone
US FDA approves its supplemental Biologics License Application for ILUMYA (tildrakizumab-asmn) in adults with active psoriatic arthritis, expanding the IL-23 inhibitor beyond its 2018 plaque psoriasis indication. ↗

The rest of Sun Pharmaceutical Industries's profile is free

Every funding round with its source, verified financials, leadership and the full journey timeline — sign in once and it stays unlocked.

One tap. No newsletter unless you ask for it.

Latest on Sun Pharmaceutical Industries

Healthcare
Sun Pharma's ILUMYA Is Approved For Psoriatic Arthritis, And Can Only Be Given In A Clinic
31 OCT 2026 · 5 MIN READ

Also in Health & Bio

Immuneel TherapeuticsBiotechnology / Cell TherapyHoola HealthHealthcare / Paediatric ClinicsBiodimensionLife Sciences / BiofabricationCARPL.aiHealthtech / Medical Imaging AI

Frequently Asked

What is Sun Pharmaceutical Industries?

Mumbai-headquartered pharmaceutical company, India's largest by revenue and among the world's biggest generic drugmakers. It has been shifting its earnings mix towards specialty products in dermatology, ophthalmology and oncology, with ILUMYA among its lead specialty assets. Listed on the NSE and BSE.

What is the latest news on Sun Pharmaceutical Industries?

The most recent StartupFox coverage is “Sun Pharma's ILUMYA Is Approved For Psoriatic Arthritis, And Can Only Be Given In A Clinic” (31 October 2026). All stories are listed on this page.

Sources & updates

This profile is compiled by the StartupFox desk from company announcements, regulatory and exchange filings (RoC/MCA, NSE/BSE) and our own reporting.

Last updated
How we verify
Sourcing standards
Spot an error?
Request a correction